On Air Now

Listen

Listen Live Now » 100.3 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
77° Feels Like: 79°
Wind: SW 9 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 56°

Tomorrow

Mostly Sunny 81°

Wed Night

Thunderstorms Late 67°

Alerts

FDA postpones panel for Glaxo's COPD drug as snowstorm advances

A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville
A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville

(Reuters) - The Food and Drug Administration said on Tuesday it has postponed a meeting of outside advisers scheduled for March 7 to review a drug developed by GlaxoSmithKline Plc and Theravance Inc for chronic obstructive pulmonary disease (COPD).

The agency did not officially give a reason for the postponement but it comes as a major snowstorm bears down on the Northeastern United States, including Washington D.C., where the panelists were due to meet.

The agency said it would post briefing materials related to the drug, to be called Breo if approved in the United States, no later than two days before the next meeting, once announced.

(Reporting By Toni Clarke in Washington)

Comments